These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21750222)

  • 1. Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells.
    Chircop M; Perera S; Mariana A; Lau H; Ma MP; Gilbert J; Jones NC; Gordon CP; Young KA; Morokoff A; Sakoff J; O'Brien TJ; McCluskey A; Robinson PJ
    Mol Cancer Ther; 2011 Sep; 10(9):1553-62. PubMed ID: 21750222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression.
    Joshi S; Braithwaite AW; Robinson PJ; Chircop M
    Mol Cancer; 2011 Jun; 10():78. PubMed ID: 21708043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells.
    Joshi S; Perera S; Gilbert J; Smith CM; Mariana A; Gordon CP; Sakoff JA; McCluskey A; Robinson PJ; Braithwaite AW; Chircop M
    Mol Cancer Ther; 2010 Jul; 9(7):1995-2006. PubMed ID: 20571068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
    Hill TA; Gordon CP; McGeachie AB; Venn-Brown B; Odell LR; Chau N; Quan A; Mariana A; Sakoff JA; Chircop M; Robinson PJ; McCluskey A
    J Med Chem; 2009 Jun; 52(12):3762-73. PubMed ID: 19459681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase.
    Robertson MJ; Deane FM; Robinson PJ; McCluskey A
    Nat Protoc; 2014 Apr; 9(4):851-70. PubMed ID: 24651498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which synthetic 6,7-annulated-4-substituted indole compounds with anti-proliferative activity disrupt mitosis and block cytokinesis in human HL-60 tumor cells in vitro.
    Perchellet JP; Perchellet EM; Singh CR; Monnett MT; Studer ER; Thornton PD; Brown N; Hill D; Neuenswander B; Lushington GH; Santini C; Buszek KR
    Anticancer Res; 2014 Apr; 34(4):1643-55. PubMed ID: 24692693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynole 34-2 and Acrylo-Dyn 2-30, Novel Dynamin GTPase Chemical Biology Probes.
    Baker JR; O'Brien NS; Prichard KL; Robinson PJ; McCluskey A; Russell CC
    Methods Mol Biol; 2022; 2417():221-238. PubMed ID: 35099803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of autophagy enhances dynamin inhibitor-induced apoptosis via promoting Bak activation and mitochondrial damage in human Jurkat T cells.
    Hee Kim Y; Kim KY; Jun do Y; Kim JS; Kim YH
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1609-16. PubMed ID: 27586274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical Inhibitors of Dynamin Exert Differential Effects in VEGF Signaling.
    Basagiannis D; Zografou S; Goula E; Gkeka D; Kolettas E; Christoforidis S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations.
    Labrière C; Talapatra SK; Thoret S; Bougeret C; Kozielski F; Guillou C
    Bioorg Med Chem; 2016 Feb; 24(4):721-34. PubMed ID: 26778612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
    Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis.
    Salmela AL; Pouwels J; Kukkonen-Macchi A; Waris S; Toivonen P; Jaakkola K; Mäki-Jouppila J; Kallio L; Kallio MJ
    Exp Cell Res; 2012 Mar; 318(5):578-92. PubMed ID: 22227008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities.
    Hu CB; Chen CP; Yeh TK; Song JS; Chang CY; Chuu JJ; Tung FF; Ho PY; Chen TW; Lin CH; Wang MH; Chang KY; Huang CL; Lin HL; Li WT; Hwang DR; Chern JH; Hwang LL; Chang JY; Chao YS; Chen CT
    Cancer Sci; 2011 Jan; 102(1):182-91. PubMed ID: 21040217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
    Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
    Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
    Kockx M; Karunakaran D; Traini M; Xue J; Huang KY; Nawara D; Gaus K; Jessup W; Robinson PJ; Kritharides L
    PLoS One; 2014; 9(10):e111186. PubMed ID: 25347775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicity.
    Ahn S; Duke CB; Barrett CM; Hwang DJ; Li CM; Miller DD; Dalton JT
    Mol Cancer Ther; 2010 Nov; 9(11):2859-68. PubMed ID: 20829196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy.
    Du J; Yan L; Torres R; Gong X; Bian H; Marugán C; Boehnke K; Baquero C; Hui YH; Chapman SC; Yang Y; Zeng Y; Bogner SM; Foreman RT; Capen A; Donoho GP; Van Horn RD; Barnard DS; Dempsey JA; Beckmann RP; Marshall MS; Chio LC; Qian Y; Webster YW; Aggarwal A; Chu S; Bhattachar S; Stancato LF; Dowless MS; Iversen PW; Manro JR; Walgren JL; Halstead BW; Dieter MZ; Martinez R; Bhagwat SV; Kreklau EL; Lallena MJ; Ye XS; Patel BKR; Reinhard C; Plowman GD; Barda DA; Henry JR; Buchanan SG; Campbell RM
    Mol Cancer Ther; 2019 Dec; 18(12):2207-2219. PubMed ID: 31530649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
    Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
    Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
    Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
    Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetraploidization increases sensitivity to Aurora B kinase inhibition.
    Marxer M; Foucar CE; Man WY; Chen Y; Ma HT; Poon RY
    Cell Cycle; 2012 Jul; 11(13):2567-77. PubMed ID: 22722494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.